Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

MAP7D2 Activators

MAP7D2 activators encompass a diverse range of chemical compounds that can engage with cellular microtubule networks and the proteins that regulate them. These activators are characterized by their ability to modulate the interaction between MAP7D2 and microtubules, either by stabilizing the microtubules themselves or by affecting the activity of MAP7D2 directly. Through stabilizing microtubules, activators ensure a more robust scaffold for MAP7D2 to bind, thereby enhancing the functional presence of MAP7D2 within the cell. Some members of this class achieve this by binding to tubulin, the building block of microtubules, which leads to the polymerization and stabilization of these intracellular structures. Others might operate by inhibiting the enzymes that dephosphorylate proteins, thus maintaining the phosphorylation status that is crucial for the activation of MAP7D2. This class also includes compounds that can activate key signaling pathways, resulting in the phosphorylation of MAP7D2 or proteins associated with it, which in turn can modulate MAP7D2 activity.

The chemical agents within the MAP7D2 activators class also encompass molecules that interact with specific kinase pathways or enzymatic functions, indirectly influencing MAP7D2's role in microtubule dynamics. By manipulating the pathways that regulate protein phosphorylation, these activators can alter the conformation and function of MAP7D2, leading to changes in its interaction with microtubules. Additionally, some compounds can cause disassembly of microtubules, which leads to a cellular response that may include an upregulation of MAP7D2 activity as part of the cellular effort to re-establish the microtubule network. The overall effects of this class of activators are multifaceted, with each compound producing distinct changes in microtubule dynamics or MAP7D2 regulation, which can collectively or individually contribute to the modulation of MAP7D2 activity within cells.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Epothilone B, Synthetic

152044-54-7sc-203944
2 mg
$176.00
(0)

Epothilone B also binds to β-tubulin and stabilizes microtubules, preventing their disassembly. It could possibly activate MAP7D2 by providing a stable microtubule network for MAP7D2 to associate with.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin increases intracellular cAMP levels, activating PKA. PKA can phosphorylate microtubule-associated proteins, which could possibly activate MAP7D2 by altering its affinity or binding characteristics to microtubules.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA activates PKC, which can phosphorylate a wide array of proteins, including those associated with microtubules. PKC-mediated phosphorylation could possibly activate MAP7D2, potentially enhancing its microtubule-stabilizing activity.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Lithium chloride inhibits GSK-3β, leading to reduced phosphorylation of substrates. This could possibly activate MAP7D2 by affecting the stability and activity of microtubule-associated proteins in a stabilizing manner.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$285.00
$520.00
$1300.00
78
(4)

Okadaic acid inhibits serine/threonine phosphatases like PP1 and PP2A, which may lead to a net increase in protein phosphorylation, including that of MAP7D2 or its associated partners, and could possibly activate MAP7D2.

Calyculin A

101932-71-2sc-24000
sc-24000A
sc-24000B
sc-24000C
10 µg
100 µg
500 µg
1 mg
$160.00
$750.00
$1400.00
$3000.00
59
(3)

Calyculin A inhibits PP1 and PP2A, similar to okadaic acid, and could lead to increased phosphorylation of MAP7D2 or its interacting proteins, which could possibly activate MAP7D2.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB 203580 selectively inhibits p38 MAP Kinase, which could affect downstream proteins that regulate microtubule dynamics. Altered signaling through this pathway could possibly activate MAP7D2 in response to changes in cellular stress or cytokine signals.